Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Tue, 25 Sep 18 20:46:57 +0000 Tue, 25 Sep 18 20:46:57 +0000 FDA Awarding Grants for Research into Rare Diseases The FDA awarded the grants through the&nbsp;Orphan Products Clinical Trials Grants Program.&nbsp; Tue, 25 Sep 18 13:59:00 +0000 FDA OKs Duvelisib for Some Lymphomas The CLL/SLL indication is a standard approval and the follicular lymphoma indication is an accelerated approval contingent on the results of a confirmatory trial Tue, 25 Sep 18 09:43:00 +0000 Role of 'Medicine Experts' to Be Highlighted on World Pharmacists Day World Pharmacists Day is being celebrated Tuesday around the globe. Mon, 24 Sep 18 19:00:00 +0000 Monday Pharmaceutical Mystery: September 24 Can you solve the pharmaceutical mystery? Each week, a new case study is presented.&nbsp; Mon, 24 Sep 18 14:00:00 +0000 Summit on Drug Shortages Explores Disaster Impacts on Supply Chain A coalition of health care industry leaders hosted a meeting Thursday in Washington, DC, to examine how to address this problem. Fri, 21 Sep 18 20:51:00 +0000 Generic Dalfampridine Tablet Marketed for Patients With MS Mylan&rsquo;s new Dalfampridine Extended-Release Tablets, 10 mg, an authorized generic version of Acorda&#39;s Ampyra&reg; is being marketed to treat adult patients with multiple sclerosis. Fri, 21 Sep 18 16:30:00 +0000 Report: Death Rates Increase for 5 of the 12 Leading Causes of Mortality Health, United States, 2017&nbsp;includes an in-depth special feature that discusses mortality in America. Fri, 21 Sep 18 09:49:00 +0000 Rite Aid Officials: Grief Counselors Will Be Available As Long As Needed The social media post noted that grief counselors will be made available to associates and &quot;will remain available as long as they are needed.&quot; Thu, 20 Sep 18 19:52:00 +0000 FDA Analysis Concludes No Unexpected Safety Risks Associated With Pimavanserin The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label, in an analysis of all available data. Thu, 20 Sep 18 19:30:00 +0000 Health Gains from Universal Coverage Driven By Quality Care Implementation of universal health care is part of the Sustainable Development Goals (SDGs), which are new targets signed by 193 United Nations member states to improve health and development by 2030. Wed, 19 Sep 18 16:11:00 +0000 Clinic Operators, Physician Found Guilty of Medicare Fraud According to evidence presented at trial, from approximately December 2011 to August 2015, Ramirez, Shepherd and Nwoko conspired and schemed to defraud Medicare out of payments for medical services. Wed, 19 Sep 18 15:37:00 +0000 New Treatment for Plaque Psoriasis Approved in Europe Almirall has received European Commission approval for its plaque psoriasis treatment tildrakizumab (Ilumetri). Tue, 18 Sep 18 14:00:00 +0000 Hereditary Angioedema: The Pharmacist's Role in Team-Based Patient Care As medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care. Mon, 17 Sep 18 20:21:00 +0000 Study Identifies Potential Target to Reduce Liver Damage, Prevent Cancer Researchers have identified a potential point of intervention that could prevent the progression of liver damage to cancer. Mon, 17 Sep 18 19:11:00 +0000 Monday Pharmaceutical Mystery: September 17 Can you solve the pharmaceutical mystery? Each week, a new case study is presented.&nbsp; Mon, 17 Sep 18 14:00:00 +0000 FDA Approves Drug Treatment to Prevent Migraines Officials with the FDA have approved fremanezumab-vfrm (Ajovy, Teva) for the preventive treatment of migraine in adults. Fri, 14 Sep 18 22:26:00 +0000 New Treatment for Hairy Cell Leukemia Granted FDA Approval Officials with the FDA have approved AstraZeneca&rsquo;s moxetumomab pasudotox-tdfk (Lumoxiti) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least 2 prior systemic therapies. Fri, 14 Sep 18 10:00:00 +0000 Preparing for Medication Safety, Accessibility During a Natural Disaster Having an emergency plan helps pharmacists, pharmacies, and patients protect themselves and their medications, during a disaster event and in the aftermath. Wed, 12 Sep 18 15:06:00 +0000 Study Shows Azathioprine Linked to Increased Skin Cancer Risk Azathioprine is known to cause increased photosensitivity to UVA light, but the new findings indicate an association between the drug and the mutational signature found in cases of cutaneous squamous cell carcinoma. Wed, 12 Sep 18 14:55:00 +0000 Drug Misuse Rates Remain Constant at High Levels More than half of Americans tested misused their prescription drugs in 2017. Tue, 11 Sep 18 12:41:00 +0000 Pharmacogenomics: Implementation in Pharmacy Practice At the International Pharmaceutical Federation (FIP) World Congress in Glasgow Scotland, speakers reviewed principles of pharmacogenomics and demonstrated useful strategies for utilizing pharmacogenomics in a clinical setting. Sun, 09 Sep 18 15:00:00 +0000 FDA Drug Information Specialists LinkedIn Group Connects Pharmacists GADIS was first launched in December 2011 to connect practicing DI specialists to each other and promote information sharing among pharmacists. Sun, 09 Sep 18 13:16:00 +0000 New Immune Globulin Formulation for Hepatitis A, Measles Post-Exposure Prophylaxis Approved by FDA Officials with the FDA have approved Grifols&rsquo; new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.<br /> &nbsp; Sat, 08 Sep 18 19:00:00 +0000 FDA Approves New Dosage Strength of Buprenorphine and Naloxone Sublingual Film for Opioid Dependence Treatment Officials with the FDA have approved a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film (Cassipa, Teva Pharmaceuticals) for the maintenance treatment of opioid dependence. Sat, 08 Sep 18 17:00:00 +0000 Innovations and New Approaches for Biological Drugs Presenters delved into the topic of biological drugs and gene therapy during the recent International Pharmaceutical Federation (FIP) World Congress in Glasgow Scotland. Sat, 08 Sep 18 14:00:00 +0000